Application 202111
- Type
- ANDA
- Sponsor
- HOSPIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | INJECTABLE;INJECTION | 100MG | No | No |
| 002 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | INJECTABLE;INJECTION | 500MG | No | No |
| 003 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | POWDER;INTRAVENOUS | EQ 1GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202111-001 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | ||
| A202111-002 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | ||
| A202111-003 | PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | AP | 2022-05-25 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | AP | 2022-05-25 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | AP | 2022-05-25 | 5c6f7cd8ea54… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A202111-003 | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A202111-001 | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A202111-002 | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER / INTRAVENOUS | 2022-05-25 | 3bdfa0b2c4d7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202111-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202111-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202111-003 | AP | 1 | 5c6f7cd8ea54… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202111-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202111-002 | AP | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202111-003 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A202111-001 | AP | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A202111-002 | AP | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A202111-003 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A202111-001 | AP | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A202111-002 | AP | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A202111-003 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202111-001 | AP | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202111-002 | AP | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202111-003 | AP | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MEXILETINE HYDROCHLORIDE | MEXILETINE HYDROCHLORIDE | Senores Pharmaceuticals, Inc. | c4a60f9e-fed1-4172-adc4-0be84ac65db9 | 2023-06-16 | Boxed warning, Warnings, Adverse reactions | 202111 ANDA202111 82012-027 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 82012-027 | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | Senores Pharmaceuticals, Inc. | ANDA | Current |